Column

The Nobel Prize for medicine and physiology was awarded last Monday to Drs. James Allison and Tasuku Honjo for their discoveries which led to the development of immunotherapy, a new anticancer strategy based on the destruction of tumors by stimulation of the immune system. Let’s take a look at the good and the less-good sides of this new class of therapeutic agents. Download the column